Apply now: Bristol Myers Squibb’s Golden Ticket—$50K lab credit to LabCentral >

All Press Releases

Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs January 7, 2018

Affinivax $6.99 million Fundraising. Steven Brugger Released Jan 5 SEC form January 5, 2018

Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients’ Lives January 5, 2018

LabCentral Gallery 1832 Features Large-Scale, Neo-Expressionist, Figurative Work by Boston-Area Artist, Sorin Bica December 19, 2017

Amgen Teams Up With Cambridge Biotech Community To Select Two Startups To Receive Golden Tickets At LabCentral December 15, 2017

Tissue Modeling May Cut Clinical Trial Time December 6, 2017

Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board December 6, 2017

Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board. Appointment Further Bolsters Strong Board Which Includes Drs. Colón and Tweed-Kent.BOSTON, Ma, December 5, 2017 – Cocoon…Read full post

Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products December 6, 2017

Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to Neutrolis, Remora Therapeutics November 28, 2017

Navitor Pharmaceuticals to Develop NV-5138, a Specific Activator of mTORC1 for Treatment-Resistant Depression, Based on Promising Data Presented at Society for Neuroscience 2017 November 15, 2017

1 ... 10 11 12 ... 22